Hofer & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Hofer & Associates's ABBV Position: Q1 2026 in Review
Hofer & Associates increased its AbbVie (ABBV) stake by 2.1% in Q1 2026, buying an estimated $14.4K and bringing the position to 3,225 shares worth $701K. The position accounts for 0.38% of the portfolio, ranked #34.
Hofer & Associates first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. The position peaked at $726K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Hofer & Associates held 3,225 shares of AbbVie worth $701K as of Q1 2026.
- Hofer & Associates bought 65 AbbVie shares in Q1 2026, an estimated $14.4K.
- AbbVie made up 0.38% of Hofer & Associates's portfolio in Q1 2026, its #34 holding.
- Hofer & Associates first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
- Hofer & Associates's AbbVie position peaked at $726K in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Hofer & Associates's 13F filing for Q1 2026, filed 22 Apr 2026.